Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Prostate cancer screening: Not a straightforward decision 9/13/2021 by John Matulis, III, D.O., M.P.H. In some men, prostate cancer can be dangerous. However, most...

Biomarkers that can improve risk stratification of patients with prostate cancer are urgently needed. In this Review, Khoo et al. outline mass spectrometry technologies...

MRI-assisted radiosurgery (MARS) is a modern technique used to treat prostate cancer. Steven Frank, M.D., explains how this type of treatment provides more precise...

ESMO 2021 phase I/II study of dose-escalation study of a fractionated (dose-dense) treatment regime, treatment regime of 177Lu-PSMA-617 for metastatic castration-resistant prostate cancer (mCRPC),...

Alicia Morgans, MD, MPH, is joined by Michael Morris, MD, to discuss the phase III VISION trial results and the practice-changing implications when lutetium-177-PSMA-617...

PSMA-targeted PET imaging with piflufolastat F 18, (NCCN) Guidelines® for prostate cancer, PYLARIFY® (piflufolastat F 18) injection, PET imaging of PSMA positive lesions in men with...

ESMO 2021 olaparib in combination with Bipolar Androgen Therapy (BAT) for men with metastatic castration-resistant prostate cancer...

Mashup Score:1

Cleveland Clinic

Events Calendar | Cleveland Clinic - 4 hours

Mashup Score:1

Welcome to our Events Calendar featuring events across the Cleveland Clinic health...

OncLive/Institutional Perspectives in Cancer/Prostate Cancer/September 16,...

The researchers did identify several other factors that were independent predictors of cancer-specific mortality in this patient...